Related Experiment Video

Updated: Aug 7, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
07:43

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas

Published on: January 17, 2018

New aspects in the diagnosis and treatment of Cushing disease

M Labeur1, M Theodoropoulou, C Sievers

  • 1Max-Planck-Institute of Psychiatry, Munich, Germany.

Frontiers of Hormone Research
|July 1, 2006
PubMed

Insights

Cushing disease diagnosis and treatment remain challenging. This review explores new drug therapies like cabergoline and SOM230, and nuclear receptors for managing pituitary tumors.

Area of Science:

  • Endocrinology
  • Oncology
  • Pharmacology

Background:

  • Cushing disease, driven by excess ACTH, presents diagnostic and therapeutic challenges.
  • Current diagnostic methods require a complex, multi-step approach.
  • Transsphenoidal surgery is the primary treatment, but not universally curative.

Purpose of the Study:

  • To review current diagnostic strategies for Cushing syndrome.
  • To examine emerging pharmacological treatments for Cushing disease.
  • To discuss novel therapeutic targets for pituitary tumors.

Main Methods:

  • Review of recent studies on drug therapies for Cushing disease.
  • Analysis of the role of nuclear receptors in pituitary tumor treatment.
  • Summary of a consensus-based diagnostic algorithm.

Main Results:

  • New drugs like cabergoline and SOM230 show therapeutic potential.
  • Nuclear receptors (retinoic acid, PPAR-gamma) are investigated as novel treatment approaches.
  • A structured diagnostic cascade is essential for accurate diagnosis.

Conclusions:

  • Accurate diagnosis of Cushing disease necessitates a systematic approach.
  • Emerging drug therapies offer new hope for patients unresponsive to surgery.
  • Targeting nuclear receptors presents a promising avenue for pituitary tumor treatment.

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...